UBS MSCI Switzerland 20/35 UCITS ETF(hedged GBP)A-dis is a equity ETF from UBS tracking the UBS Lux Fund Solutions – MSCI Switzerland 20/35 index through physical replication. Domiciled in Luxembourg and launched in 2015, the fund manages about 114 M € and charges a TER of 0.23% — 23 € per year on a €10,000 investment. Income is paid out to investors periodically (distributing).
| Roche Holding AG | 13.8% |
| Novartis AG | 13.4% |
| Nestle S.A. | 12.9% |
| UBS Group AG | 8.3% |
| ABB Ltd | 8.0% |
| Compagnie Financière Richemont SA | 5.9% |
| Zurich Insurance Group AG | 5.5% |
| Lonza Group AG | 2.5% |
| Swiss Re AG | 2.4% |
| Holcim Ltd | 2.3% |
| London Stock Exchange | UC94 | GBX |
Source: the fund's KID and the issuer's official documentation — data verified as of July 2026.
This page is informational and is not an investment recommendation. Figures may contain errors or be out of date: always check the KID and the issuer's factsheet before any decision.